Halozyme Therapeutics Inc (NASDAQ: HALO) Is Up 10.04% Year-To-Date, But Analysts Find Room For A Price Rally
Halozyme Therapeutics Inc (NASDAQ:HALO) traded at $52.61 at last check on current trade day and made an upward move of 2.78% on its previous day’s price. Looking at the stock we see that its previous close was $51.19 and the beta (5Y monthly) reads 1.29